"Sphera Pharma" LLC was created in 2008. Since 2011, the company has been a member of the "Pharmaceuticals, biotechnology, and biomedicine" cluster of Kaluga region, that was given the status of a pilot innovative territorial cluster of RF by the Resolution of the Government of the Russian Federation N188 dated March 6, 2013. At present, the company has completed the licensing process for infusion, parenteral nutrition and peritoneal dialysis solutions production plant complying with GMP requirements.
The main goals of the company are:
- Manufacture of sterile medicinal products to provide import substitution
- Production of amino acid based drugs almost without analogs on the territory of the Russian Federation
- Production of systems for peritoneal dialysis
- The release of blood products widely used in medical practice
The high efficiency, high quality and low cost of the drugs scheduled for release provide all the prospects for significant substitution of imported and domestic counterparts in the pharmaceutical market of Russia and, in addition, for saturation of the existing deficit.